Takeda Pharmaceutical to exit cell therapy research

Core Viewpoint - Takeda Pharmaceutical will discontinue its cell therapy research and seek a partner to advance its candidates under development [1] Company Summary - Takeda Pharmaceutical is shifting its strategy by halting its internal cell therapy research efforts [1] - The company is actively looking for a partner to help progress its cell therapy candidates that are currently in development [1] Industry Summary - The decision reflects a broader trend in the pharmaceutical industry where companies are reassessing their research and development strategies, particularly in complex fields like cell therapy [1]